Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response to doxycycline and azithromycin therapy and ACE polymorphism in moderate acne vulgaris
IRCT20230305057628N1Phase 2Completed
- Sponsor
- Gonabad University of Medical Sciences
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of doxycycline and azithromycin in acne vulgaris (2 arms), sponsored by Gonabad University of Medical Sciences. Started Mar 2023; status: completed.
02
Drugs
doxycyclineazithromycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20230305057628N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230305057628N1.